Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The Office of Generic Drugs (OGD) began publishing bioequivalence (BE) recommendations for specific (complex/non-complex) products in 2007 to support generic drug development. Nevertheless, little is known about patterns of BE recommendations. The purpose of this study was to describe patterns of BE recommendations published by the OGD and trends of abbreviated new drug application (ANDA) approvals over time.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.